Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Urologic Oncology|September 16, 2017
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 studyAndrea Necchi, Salvatore Lo Vullo, Daniele Raggi, et al.
Clinical Genitourinary Cancer|May 1, 2018
Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of ImmunotherapyGuru Sonpavde, Gregory Russell Pond, Jonathan E Rosenberg, et al.
Clinical Genitourinary Cancer|December 24, 2013
Predictors of CD34+ cell mobilization and collection in adult men with germ cell tumors: implications for the salvage treatment strategyAndrea Necchi, Rosalba Miceli, Paolo Pedrazzoli, et al.
BJU International|July 30, 2019
Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissectionJuan Chipollini, Mounsif Azizi, Salvatore Lo Vullo, et al.
Critical Reviews in Oncology/Hematology|May 8, 2023
A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS studyGiorgio Bogani, Michela Cinquini, Diego Signorelli, et al.
Clinical Genitourinary Cancer|May 3, 2014
Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinomaPatrizia Giannatempo, Alessandra Alessi, Rosalba Miceli, et al.
Urologic Oncology|October 19, 2020
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumabLaura Marandino, Antonella Capozza, Marco Bandini, et al.
Urologic Oncology|November 11, 2022
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy-A large, retrospective, single-center studyGiuseppe Rosiello, Alessandro Larcher, Giuseppe Fallara, et al.
Urologic Oncology|June 20, 2021
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02Andrea Necchi, Alberto Martini, Daniele Raggi, et al.
European Urology Focus|November 11, 2020
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical CystectomyLaura Marandino, Antonella Capozza, Marco Bandini, et al.
Pageof 13